LANTERN PHARMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Sept 2025)
What this means for you
Registered since 28 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88612435
- Registration number
- 5973379
- Mark type
- Stylized text
- Filed
- 11 Sept 2019
- Published for opposition
- 12 Nov 2019
- Registered
- 28 Jan 2020
- Attorney of record
- Nigamnarayan Acharya
Goods and services
- Class 042 — Scientific and technological services: drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology
Owner
- LANTERN PHARMA INC, DALLAS, TX, US
- Lantern Pharma Inc., Dallas, TX, US
- Lantern Pharma Inc., Dallas, TX, US
- Lantern Pharma Inc., Dallas, TX, US
Prosecution history
- 18 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 28 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Jan 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Jan 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jan 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jan 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jan 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 May 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2019 — PUBLISHED FOR OPPOSITION
- 23 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED